Intercept Pharmaceuticals, Inc.
Steroids as agonists for FXR
Last updated:
Abstract:
The invention relates to compounds of formula (I): ##STR00001## wherein R is ethyl, propyl or allyl, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists.
Status:
Grant
Type:
Utility
Filling date:
10 Jul 2017
Issue date:
24 Sep 2019